Citation Impact
Citing Papers
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
2010
Plants send small RNAs in extracellular vesicles to fungal pathogen to silence virulence genes
2018 StandoutScience
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Untangling the ErbB signalling network
2001 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Direct observation of ligand recognition by T cells
2002 Nature
Epidermal growth factor receptor tyrosine kinase
1994
Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes
2007
Superantigen-Dependent, Cell-Mediated Cytotoxicity Inhibited by MHC Class I Receptors on T Lymphocytes
1995 Science
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells
2002
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
A New Twist in TCR Diversity Revealed by a Forbidden αβ TCR
2007 StandoutNobel
The type III epidermal growth factor receptor mutation
2001
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
2008
DC-SIGN
2000 StandoutNobel
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Activation with superantigens induces programmed death in antigen‐primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18‐dependent mechanism
1993
The α Chain of the T Cell Antigen Receptor Is Degraded in the Cytosol
1997
CD28 as a Molecular Amplifier Extending TCR Ligation and Signaling Capabilities
2001
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1
2000
Human T-cell receptor variable gene segment families
1995
Two common structural motifs for TCR recognition by staphylococcal enterotoxins
2016 StandoutNobel
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors
2002
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity
2022
Targeted Molecular Therapy of GBM
2003
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
1994 StandoutNobel
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target
1998
Malignant Gliomas in Adults
2008 Standout
Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian Cells
1998
Inhibiting kinases in malignant gliomas
2007
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
2011
Primary brain tumours in adults
2012 Standout
T cell receptor antagonist peptides induce positive selection
1994 Standout
Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I‐bound determinant
1993
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
1993
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands
2010
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Identification of human brain tumour initiating cells
2004 StandoutNature
Superantigens and Their Potential Role in Human Disease
1993
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice
1998 Nobel
Exosomes: composition, biogenesis and function
2002 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
2012
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
1993
Fas ligand mediates activation-induced cell death in human T lymphocytes.
1995 StandoutNobel
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
1998 StandoutScience
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The lymphoproliferative defect in CTLA-4–deficient mice is ameliorated by an inhibitory NK cell receptor
2002 StandoutNobel
Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
1996
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis
2003
A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities
2000
Novel Aspects of Degradation of T Cell Receptor Subunits from the Endoplasmic Reticulum (ER) in T Cells: Importance of Oligosaccharide Processing, Ubiquitination, and Proteasome-dependent Removal from ER Membranes
1998 StandoutNobel
Calcitonin Gene-Related Peptide Decreases Expression of HLA-DR and CD86 by Human Dendritic Cells and Dampens Dendritic Cell-Driven T Cell-Proliferative Responses Via the Type I Calcitonin Gene-Related Peptide Receptor
2000 StandoutNobel
Molecular Targeting and Treatment of EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibody L8A4
2006
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Cancer Genome Landscapes
2013 StandoutScience
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure.
1995
HIV-1 Nef impairs MHC class II antigen presentation and surface expression
2001
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
A natural mutation of the amino acid residue at position 60 destroys staphylococcal enterotoxin A murine T-cell mitogenicity
1995
Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting
2006
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL
2002 StandoutNobel
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Bacterial pyrogenic exotoxins as superantigens
1995
Virus and Autoimmunity: Induction of Autoimmune Disease in Mice by Mouse T Lymphotropic Virus (MTLV) Destroying CD4+ T Cells
1999 StandoutNobel
Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.
1995 StandoutNobel
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
2000
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses
2012 StandoutNobel
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Mark Hill being referenced
Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide
1989
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
1995
Differential Requirements for CD4 in TCR-Ligand Interactions
1999
Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor.
1992